These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38515945)

  • 1. From prediction to prevention: Machine learning revolutionizes hepatocellular carcinoma recurrence monitoring.
    Ramírez-Mejía MM; Méndez-Sánchez N
    World J Gastroenterol; 2024 Feb; 30(7):631-635. PubMed ID: 38515945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine.
    Ravikulan A; Rostami K
    World J Gastroenterol; 2024 Feb; 30(5):424-428. PubMed ID: 38414588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma.
    Zhang YB; Yang G; Bu Y; Lei P; Zhang W; Zhang DY
    World J Gastroenterol; 2023 Nov; 29(43):5804-5817. PubMed ID: 38074914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning algorithms based on proteomic data mining accurately predicting the recurrence of hepatitis B-related hepatocellular carcinoma.
    Feng G; He N; Xia HH; Mi M; Wang K; Byrne CD; Targher G; Yuan HY; Zhang XL; Zheng MH; Ye F
    J Gastroenterol Hepatol; 2022 Nov; 37(11):2145-2153. PubMed ID: 35816347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.
    Calderaro J; Seraphin TP; Luedde T; Simon TG
    J Hepatol; 2022 Jun; 76(6):1348-1361. PubMed ID: 35589255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting hepatocellular carcinoma recurrences: A data-driven multiclass classification method incorporating latent variables.
    Xu D; Sheng JQ; Hu PJ; Huang TS; Lee WC
    J Biomed Inform; 2019 Aug; 96():103237. PubMed ID: 31238108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
    Audureau E; Carrat F; Layese R; Cagnot C; Asselah T; Guyader D; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Chazouillères O; Mallat A; Grangé JD; Attali P; d'Alteroche L; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Pol S; Nahon P;
    J Hepatol; 2020 Dec; 73(6):1434-1445. PubMed ID: 32615276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Models for Prediction of Posttreatment Recurrence in Early-Stage Hepatocellular Carcinoma Using Pretreatment Clinical and MRI Features: A Proof-of-Concept Study.
    Iseke S; Zeevi T; Kucukkaya AS; Raju R; Gross M; Haider SP; Petukhova-Greenstein A; Kuhn TN; Lin M; Nowak M; Cooper K; Thomas E; Weber MA; Madoff DC; Staib L; Batra R; Chapiro J
    AJR Am J Roentgenol; 2023 Feb; 220(2):245-255. PubMed ID: 35975886
    [No Abstract]   [Full Text] [Related]  

  • 10. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma.
    Cheng B; Zhou P; Chen Y
    BMC Bioinformatics; 2022 Jun; 23(1):248. PubMed ID: 35739471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium.
    Tran BV; Moris D; Markovic D; Zaribafzadeh H; Henao R; Lai Q; Florman SS; Tabrizian P; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Hoteit M; Levine MH; Cillo U; Vitale A; Verna EC; Halazun KJ; Tevar AD; Humar A; Chapman WC; Vachharajani N; Aucejo F; Lerut J; Ciccarelli O; Nguyen MH; Melcher ML; Viveiros A; Schaefer B; Hoppe-Lotichius M; Mittler J; Nydam TL; Markmann JF; Rossi M; Mobley C; Ghobrial M; Langnas AN; Carney CA; Berumen J; Schnickel GT; Sudan DL; Hong JC; Rana A; Jones CM; Fishbein TM; Busuttil RW; Barbas AS; Agopian VG
    Liver Transpl; 2023 Jul; 29(7):683-697. PubMed ID: 37029083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Toronto Postliver Transplantation Hepatocellular Carcinoma Recurrence Calculator: A Machine Learning Approach.
    Ivanics T; Nelson W; Patel MS; Claasen MPAW; Lau L; Gorgen A; Abreu P; Goldenberg A; Erdman L; Sapisochin G
    Liver Transpl; 2022 Apr; 28(4):593-602. PubMed ID: 34626159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of RETREAT and CCFSS Scoring Systems for Risk Estimation of Hepatocellular Carcinoma Recurrence After Radical Resection.
    Zhang S; Zhang X; Mo C; Luo Y
    Altern Ther Health Med; 2023 Nov; 29(8):694-698. PubMed ID: 37678878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study.
    Liu R; Wu S; Yu HY; Zeng K; Liang Z; Li S; Hu Y; Yang Y; Ye L
    Heliyon; 2023 Nov; 9(11):e22458. PubMed ID: 38034691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting postoperative liver cancer death outcomes with machine learning.
    Wang Y; Ji C; Wang Y; Ji M; Yang JJ; Zhou CM
    Curr Med Res Opin; 2021 Apr; 37(4):629-634. PubMed ID: 33539249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma.
    Fu Y; Si A; Wei X; Lin X; Ma Y; Qiu H; Guo Z; Pan Y; Zhang Y; Kong X; Li S; Shi Y; Wu H
    BMC Genomics; 2023 Feb; 24(1):89. PubMed ID: 36849926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.
    Huang JF; Yeh ML; Yu ML; Dai CY; Huang CF; Huang CI; Tsai PC; Lin PC; Chen YL; Chang WT; Hou NJ; Lin ZY; Chen SC; Chuang WL
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1768-74. PubMed ID: 26094738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learning.
    Kucukkaya AS; Zeevi T; Chai NX; Raju R; Haider SP; Elbanan M; Petukhova-Greenstein A; Lin M; Onofrey J; Nowak M; Cooper K; Thomas E; Santana J; Gebauer B; Mulligan D; Staib L; Batra R; Chapiro J
    Sci Rep; 2023 May; 13(1):7579. PubMed ID: 37165035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning.
    Saito A; Toyoda H; Kobayashi M; Koiwa Y; Fujii H; Fujita K; Maeda A; Kaneoka Y; Hazama S; Nagano H; Mirza AH; Graf HP; Cosatto E; Murakami Y; Kuroda M
    Mod Pathol; 2021 Feb; 34(2):417-425. PubMed ID: 32948835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.